JP2001513487A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001513487A5 JP2001513487A5 JP2000506830A JP2000506830A JP2001513487A5 JP 2001513487 A5 JP2001513487 A5 JP 2001513487A5 JP 2000506830 A JP2000506830 A JP 2000506830A JP 2000506830 A JP2000506830 A JP 2000506830A JP 2001513487 A5 JP2001513487 A5 JP 2001513487A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- drug
- use according
- arachidonic acid
- zinc cation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 24
- 239000000203 mixture Substances 0.000 description 24
- 239000003814 drug Substances 0.000 description 20
- 229940079593 drug Drugs 0.000 description 18
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 16
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 15
- 229940006486 zinc cation Drugs 0.000 description 15
- 229940114079 arachidonic acid Drugs 0.000 description 12
- 235000021342 arachidonic acid Nutrition 0.000 description 12
- 229960002885 histidine Drugs 0.000 description 8
- 150000001450 anions Chemical class 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- 206010012601 diabetes mellitus Diseases 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 241000124008 Mammalia Species 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- -1 zinc cations Chemical class 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/909,240 US5834032A (en) | 1997-08-11 | 1997-08-11 | Compositions and methods for treating diabetes |
| US08/909,240 | 1997-08-11 | ||
| PCT/US1998/016321 WO1999007224A1 (en) | 1997-08-11 | 1998-08-06 | Compositions and methods for treating diabetes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001513487A JP2001513487A (ja) | 2001-09-04 |
| JP2001513487A5 true JP2001513487A5 (enExample) | 2006-01-05 |
Family
ID=25426873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000506830A Pending JP2001513487A (ja) | 1997-08-11 | 1998-08-06 | 糖尿病治療用組成物及び治療方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US5834032A (enExample) |
| JP (1) | JP2001513487A (enExample) |
| KR (1) | KR100533618B1 (enExample) |
| CN (1) | CN1216635C (enExample) |
| AU (1) | AU8693098A (enExample) |
| WO (1) | WO1999007224A1 (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5750336A (en) * | 1994-02-10 | 1998-05-12 | The Salk Institute For Biological Studies | Assays for the identification of compounds which inhibit activation of cAMP and mitogen responsive genes |
| CN1324234A (zh) * | 1998-09-25 | 2001-11-28 | 格利科克斯有限公司 | 果糖胺氧化酶,拮抗剂和抑制剂 |
| JP2001220348A (ja) * | 1999-11-30 | 2001-08-14 | Japan Science & Technology Corp | 亜鉛（ｉｉ）有機錯体からなる血糖降下剤 |
| AU7931301A (en) | 2000-08-04 | 2002-02-18 | Dmi Biosciences Inc | Method of using diketopiperazines and composition containing them |
| JP4161031B2 (ja) * | 2000-10-31 | 2008-10-08 | 独立行政法人産業技術総合研究所 | 亜鉛含有リン酸カルシウム微粒子含有懸濁液または粒子溶媒混合系及び亜鉛欠乏症治療剤 |
| JP2003040784A (ja) | 2001-01-31 | 2003-02-13 | Japan Science & Technology Corp | 血糖降下剤 |
| JP4674317B2 (ja) * | 2002-10-02 | 2011-04-20 | ディエムアイ アクイジション コーポレイション | 疾病の判定および監視 |
| US6989025B2 (en) * | 2002-10-04 | 2006-01-24 | Boston Scientific Scimed, Inc. | Extruded tubing with discontinuous striping |
| WO2004064742A2 (en) * | 2003-01-17 | 2004-08-05 | Uab Research Foundation | Methods and compositions for p2x receptor calcium entry channels and other calcium entry mechanisms |
| DE602004011275T2 (de) * | 2003-01-31 | 2009-01-15 | Moon K. Northridge Song | Zusammensetzungen und Verfahren zur Behandlung von Fettleibigkeit |
| PL2537524T3 (pl) | 2003-05-15 | 2017-01-31 | Ampio Pharmaceuticals, Inc. | Leczenie chorób mediowanych przez komórki T |
| JP2008538547A (ja) * | 2005-03-09 | 2008-10-30 | ロジャー・ウィリアムズ・ホスピタル | 甲状腺刺激ホルモン放出ホルモン類縁体及び使用方法 |
| US20060280787A1 (en) * | 2005-06-14 | 2006-12-14 | Baxter International Inc. | Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof |
| WO2008109445A1 (en) * | 2007-03-02 | 2008-09-12 | Preventive Nutrient Company, Inc. | Compositions and methods for treating alzheimer's disease and dementia |
| EP2300011A4 (en) | 2008-05-27 | 2012-06-20 | Dmi Life Sciences Inc | THERAPEUTIC PROCESSES AND COMPOUNDS |
| JP2013537195A (ja) | 2010-09-07 | 2013-09-30 | ディエムアイ アクイジション コーポレイション | 疾患の治療 |
| EP2766029B1 (en) | 2011-10-10 | 2020-03-25 | Ampio Pharmaceuticals, Inc. | Treatment of degenerative joint disease |
| AU2012323320B2 (en) | 2011-10-10 | 2017-05-11 | Ampio Pharmaceuticals, Inc. | Implantable medical devices with increased immune tolerance, and methods for making and implanting |
| AU2012328605B9 (en) | 2011-10-28 | 2017-08-03 | Ampio Pharmaceuticals, Inc. | Treatment of rhinitis |
| WO2014145729A2 (en) | 2013-03-15 | 2014-09-18 | Ampio Pharmaceuticals, Inc. | Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same |
| KR20170020459A (ko) * | 2014-06-20 | 2017-02-22 | 산토리 홀딩스 가부시키가이샤 | 당 대사 개선제 |
| JP6723222B2 (ja) | 2014-08-18 | 2020-07-15 | アンピオ ファーマシューティカルズ，インコーポレイテッド | 関節病態の治療 |
| WO2016209969A1 (en) | 2015-06-22 | 2016-12-29 | Ampio Pharmaceuticals, Inc. | Use of low molecular weight fractions of human serum albumin in treating diseases |
| CN105748564A (zh) * | 2015-12-21 | 2016-07-13 | 天津中津药业股份有限公司 | 一种治疗糖尿病的药物组合物 |
| US11607441B2 (en) * | 2017-10-20 | 2023-03-21 | Novmetapharma Co., Ltd. | Pharmaceutical composition for preventing or treating diabetes, containing zinc salt, cyclo-hispro and antidiabetic drug as active ingredients |
| KR102163445B1 (ko) * | 2017-11-20 | 2020-10-07 | 주식회사 노브메타파마 | Chp(사이클로-히스프로)를 포함하는 골 손실 질환의 예방, 개선 또는 치료용 조성물 |
| US20210177932A1 (en) * | 2017-12-11 | 2021-06-17 | United States Government As Represented By The Department Of Veterans Affairs | Compositions and methods for prevention and treatment of immune deficiency and inflammation |
| KR20190074746A (ko) * | 2017-12-20 | 2019-06-28 | 주식회사 노브메타파마 | 시클로-히스프로를 유효성분으로 포함하는 당뇨병 예방 또는 치료용 약제학적 제제 |
| US20200345728A1 (en) * | 2019-04-30 | 2020-11-05 | Novmetapharma Co., Ltd. | Compositions and methods for treatment of atherosclerosis |
| KR102115353B1 (ko) * | 2019-05-17 | 2020-05-26 | 주식회사 노브메타파마 | Chp(사이클로-히스프로) 및 부갑상선 호르몬을 포함하는 골 손실 질환의 예방, 개선 또는 치료용 조성물 |
| WO2021126231A1 (en) * | 2019-12-20 | 2021-06-24 | Vector Vitale Ip Llc | Composition and method for the treatment of type i diabetes |
| WO2021255691A1 (en) * | 2020-06-17 | 2021-12-23 | Novmetapharma Co., Ltd. | Compositions and methods for treating virus infection |
| WO2022049433A1 (en) | 2020-09-04 | 2022-03-10 | Societe Des Produits Nestle Sa | Compositions and methods for providing health benefits in an animal |
| KR20240032221A (ko) * | 2022-08-31 | 2024-03-12 | 주식회사 노브메타파마 | 아연염 및 사이클로-히스프로를 유효성분으로 포함하는 호흡기 질환의 예방, 개선 또는 치료용 조성물 |
| KR20250066976A (ko) | 2023-11-07 | 2025-05-14 | 주식회사 노브메타파마 | 아연염 및 사이클로-히스프로를 유효성분으로 포함하는 당뇨병성 신증의 예방, 개선 또는 치료용 조성물 |
| KR20250076353A (ko) | 2023-11-21 | 2025-05-29 | 주식회사 노브메타파마 | 글루콘산 아연염 및 사이클로-히스프로를 유효성분으로 포함하는 비만 및 당뇨병의 예방, 개선 또는 치료용 조성물 |
-
1997
- 1997-08-11 US US08/909,240 patent/US5834032A/en not_active Expired - Lifetime
-
1998
- 1998-08-06 WO PCT/US1998/016321 patent/WO1999007224A1/en not_active Ceased
- 1998-08-06 CN CN988079313A patent/CN1216635C/zh not_active Expired - Fee Related
- 1998-08-06 JP JP2000506830A patent/JP2001513487A/ja active Pending
- 1998-08-06 AU AU86930/98A patent/AU8693098A/en not_active Abandoned
- 1998-08-06 KR KR10-2000-7001386A patent/KR100533618B1/ko not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2001513487A5 (enExample) | ||
| JP4850880B2 (ja) | 疼痛の処置のためのエピナスチンの使用 | |
| CA2492081A1 (en) | Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders | |
| JP2005537268A5 (enExample) | ||
| JPH07215859A (ja) | 月経時の症状の治療法およびそれに用いる組成物 | |
| Pasquier et al. | “Hemicrania continua”: the first bilateral case? | |
| EP0920865B1 (en) | Pharmaceutical compositions containing Norastemizole | |
| JPS59193821A (ja) | 抗不安薬としてのフルオキセチンの使用法 | |
| JPS59112948A (ja) | コレステロ−ルレベル低下剤 | |
| JP2002544227A5 (enExample) | ||
| Veterans Administration Cooperative Study Group on Antihypertensive Agents et al. | Captopril: evaluation of low doses, twice-daily doses and the addition of diuretic for the treatment of mild to moderate hypertension | |
| RU2004131214A (ru) | Способы лечения когнитивных расстройств | |
| JPS63270626A (ja) | 抗潰瘍剤 | |
| JPH037218A (ja) | 薬剤組成物 | |
| KR0178762B1 (ko) | 특정 인돌 유도체의 신규 의약적 용도 및 그를 함유하는 제약 조성물 | |
| JPS58109420A (ja) | 月経痛を減少させるための方法及び組成物 | |
| JP3792251B2 (ja) | 手術後の悪心および嘔吐の治療のためのグラニセトロンの使用 | |
| SHEIDLER et al. | Double‐blind multiple‐dose crossover study of the antiemetic effect of intramuscular levonantradol compared to prochlorperazine | |
| Bittar | Usefulness of nifedipine for myocardial ischemia and the nifedipine gastrointestinal therapeutic system | |
| Curson et al. | Mianserin and agranulocytosis. | |
| US5292497A (en) | Method of reducing chemotherapy toxicity using (methylaminopropylamino)propyl dihydrogen phosphorothioate | |
| JPH0149124B2 (enExample) | ||
| CA1256374A (en) | Bromocriptine compositions | |
| JP6087988B2 (ja) | 鼻汁分泌抑制用組成物 | |
| AU2015305430A1 (en) | Method for treating hyperhidrosis |